Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for October 20, 2014

October 20, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Medtronic's new line of spinal implants drops

October 20, 2014 by Brad Perriello

A new line of spinal implants from Medtronic makes its debut on the global stage.

Medtronic's new line of spinal implants drops worldwide

Medtronic (NYSE:MDT) said it's introduced a new line of spinal implants made of a titanium-plastic combination for interbody fusion procedures.

Ablative Solutions tests infusion ablation catheter as hypertension treatment

October 20, 2014 by Alexander Soule

Ablative Solutions begins testing its infusion ablation catheter as a potential treatment for hypertension.

Ablative Solutions tests infusion ablation catheter as hypertension treatment

Diabetes: Medtronic initiates IDE trial for new insulin management system

October 20, 2014 by Alexander Soule

Medtronic has initiated an IDE clinical trial for its latest insulin-pump system as part of its quest to develop an "artificial pancreas" for the treatment of diabetes.

Medtronic initiates IDE trial for new insulin-pump system

Boston Scientific launches stent trial for underserved demographics

October 20, 2014 by Brad Perriello

Boston Scientific launches a clinical trial examining outcomes in underserved populations with its Promus Premier drug-eluting stent.

Boston Scientific launches stent trial for underserved demographics

FDA clears AnthroTronix mobile app for PTSD, brain trauma assessment

October 20, 2014 by Alexander Soule

AnthroTronix says it won FDA clearance for an app designed to help clinicians measure reaction time in assessing conditions like post-traumatic stress disorder and traumatic brain injury.

FDA clears AnthroTronix mobile app for PTSD, brain trauma assessment

AnthroTronix said it received FDA clearance for its DANA mobile assessment app, which is designed to help clinicians measure reaction time in assessing an individual's medical or psychological state.

ZipLine Medical adds $5.7m to Series C round

October 20, 2014 by Alexander Soule

A Chinese venture capital investor takes a $5.7 million stake in incision-closure device maker ZipLine Medical.

ZipLine Medical adds $5.7m to Series C round

ZipLine Medical said it added a $5.7 million extension to its $4.3 million Series C round, with new investor China Materialia promising to help the company expand sales in the People's Republic.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp